US Patent

US10004750 — Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof

Composition of Matter · Assigned to Shionogi and Co Ltd · Expires 2035-09-03 · 9y remaining

Vulnerability score 0/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects the acid addition salt or sodium salt of a compound represented by formula (IA), and its stable crystalline solid form.

USPTO Abstract

The present invention provides an acid addition salt or a sodium salt of a compound represented by the formula (IA): or their hydrate or a stable crystalline solid thereof. The salt or the crystalline solid is extremely useful as an active ingredient for the production of a pharmaceutical product.

Drugs covered by this patent

Patent Metadata

Patent number
US10004750
Jurisdiction
US
Classification
Composition of Matter
Expires
2035-09-03
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.